ANX005

6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
Annexon becomes the latest group to provide a confusing update in Huntington's disease
EP Vantage
Wed, 01/5/22 - 10:45 am
Annexon Biosciences
Huntington's disease
clinical trials
ANX005
FDA grants fast track status to Annexon’s ANX005 to treat Guillain-Barré Syndrome
Pharmaceutical Business Review
Wed, 09/25/19 - 09:12 am
Annexon
fast track
FDA
ANX005
Guillain-Barré Syndrome